It was also interesting that re-bleeding episodes were marginally associated with re-bleeding-related mortality, even though it did not reach statistical significance (OR, 6.161, 95%; CI: 0.957–39.660, p = 0.056), which might have been caused by the small sample size.
← all excerpts
Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy.
2
0.0560
0.0560
The sentences
9.9, p = 0.543) even though they failed to reach statistical significance, which suggests the hypothesis that RS and GBS would be good predictive tools for re-bleeding and bleeding-related mortality in NVUGIB patients while taking DAPT if a sufficient number of patients were enrolled.